by Annie De Groot | Oct 26, 2017 | EpiVax Immunoncology, Thinking Out Loud -Blog
Yes, wonder drugs though they are, checkpoint inhibitors (a.k.a CPI) drive anti-drug antibodies (ADA) too. We’ve been concerned for a while that “releasing the brakes” will drive T cell response to CPI, and have been watching to see what happens....
by Annie De Groot | Sep 25, 2017 | EpiVax Immunoncology, News
EpiVax Oncology Press Release Sept 25 2017 Sept 25, 2017 (Providence, RI) – EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused on the...
by Admin Epivax | Aug 22, 2017 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
EpiVax has carved out a niche in the biotech and immunoinformatics industry with our innovative tools and discoveries. Well-situated on a trajectory Dr. De Groot described as “upward and stable,” EpiVax is now gearing up to launch a venture-backed spinoff called...
by epivax3 | Aug 3, 2017 | EpiVax Immunoncology, News, Thinking Out Loud -Blog
Accelerating the Development of a Game Changing Cancer Therapy PROVIDENCE, R.I., Aug. 3, 2017 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today announced it received funding from the Rhode Island Commerce Corporation to accelerate the development of...
by Annie De Groot | Jan 2, 2017 | EpiVax Immunoncology, News, Thinking Out Loud -Blog
EpiVax Oncology – New Year, New Endeavor! A nice story in ConvergenceRI that describes the rapid growth of EpiVax and our decision to invest in a new spin-out company in 2017: Welcome EpiVax Oncology! Annie was interviewed by Richard Asinof about “EpiVax...
by Annie De Groot | Dec 11, 2016 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing...